share_log

HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Lowers Price Target to $13

HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Lowers Price Target to $13

HC Wainwright & Co.維持對Acurx Pharmicals的買入,將目標股價下調至13美元
Benzinga ·  2023/08/15 07:15

HC Wainwright & Co. analyst Ed Arce maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and lowers the price target from $14 to $13.

HC Wainwright&Co.分析師埃德·阿爾斯維持阿科克斯製藥(納斯達克代碼:ACXP)的買入,並將目標價從14美元下調至13美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論